title: [Clinical observation on inhalation of pulmicort in patients with chronic rhinosinusitis after surgery].
abstract: OBJECTIVE
  Whether inhalation of pulmicort into the sinus of chronic rhinosinusitis patients could improve reepithelization after endoscopic sinus surgery was assessed.
  
  
  METHODS
  Prospective study 60 patients with chronic rhinosinusitis after endoscopic sinus surgery were divided into 2 groups randomized, the one was treatment group, and the other was control group. The patients in treatment group received inhalation of pulmicort 2 ml plus 0.5% Aeuromycin solution 10 ml by oxygen driving force, once a day, persisting for 3 weeks. The patients in control group received Rhinocort. Besides the different therapies above mentioned above therapy was different, two groups received the same conventional route therapy. To observe the time of reepithelization under nasal endoscope, was observed, respectively.
  
  
  RESULTS
  The average time of reepithelization in treatment group was (5.3333 +/- 0.9942) weeks. The other group was (6.6667 +/- 1.3476) weeks, the statistical difference between the two groups was very significant.
  
  
  CONCLUSIONS
  Inhalation of pulmicort into the sinus can promote reepithelization and shorten the time of treatment.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. zhtlancet@yahoo.com.cn
authors.forename: Hongtao
authors.initials: H
authors.lastname: Zhen
authors.forename: Lu
authors.initials: L
authors.lastname: Peng
authors.forename: Xiaobo
authors.initials: X
authors.lastname: Long
authors.forename: Liyan
authors.initials: L
authors.lastname: Peng
authors.forename: Dan
authors.initials: D
authors.lastname: Bing
authors.forename: Yanling
authors.initials: Y
authors.lastname: Tao
authors.forename: Qixue
authors.initials: Q
authors.lastname: Gao
authors.forename: Yonghua
authors.initials: Y
authors.lastname: Cui
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004724:Endoscopy; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D012852:Sinusitis / Q000188:drug therapy* / Q000628:therapy; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D019819:Budesonide